The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

Authors: Stack, Sophie K., Wheate, Nial J., Moloney, Niamh C., Abelev, Sarah V., Barlow, John W., Schubert, Elise A.

Source: Journal of pharmacy technology. 39(4):172-182

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN633309319&indx=1&recIds=ETOCRN633309319

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

Authors: Anderson, Lyndsey L., Absalom, Nathan L., Abelev, Sarah V., Low, Ivan K., Doohan, Peter T., Martin, Lewis J., Chebib, Mary, McGregor, Iain S., Arnold, Jonathon C.

Source: Epilepsia. 60(11):2224-2234

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100095074410.0x000001&indx=1&recIds=ETOCvdc_100095074410.0x000001

Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice

Authors: Brzozowska, Natalia I., Smith, Kristie L., Zhou, Cilla, Waters, Peter M., Cavalcante, Ligia Menezes, Abelev, Sarah V., Kuligowski, Michael, Clarke, David J., Todd, Stephanie M., Arnold, Jonathon C.

Source: In Brain Behavior and Immunity October 2017 65:251-261

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22).

Authors: Mills, Llewellyn, Arnold, Jonathon C., Suraev, Anastasia, Abelev, Sarah V., Zhou, Cilla, Arkell, Thomas R., McGregor, Iain S., Lintzeris, Nicholas

Source: Harm Reduction Journal; 5/28/2024, Vol. 21 Issue 1, p1-11, 11p

Subject Terms: MEDICAL marijuana, CRIMINAL justice system

Geographic Terms: AUSTRALIA

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.

Authors: Arkell, Thomas R., Abelev, Sarah V., Mills, Llewellyn, Suraev, Anastasia, Arnold, Jonathon C., Lintzeris, Nicholas, McGregor, Iain S.

Source: Journal of Cannabis Research; 9/6/2023, Vol. 5 Issue 1, p1-10, 10p

Subject Terms: MEDICAL marijuana, DRUGGED driving, RISK perception, MOTOR vehicle driving, ATTITUDE (Psychology), ROAD safety measures, DRUG use testing

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).

Authors: Lintzeris, Nicholas, Mills, Llewellyn, Abelev, Sarah V., Suraev, Anastasia, Arnold, Jonathon C., McGregor, Iain S.

Source: Harm Reduction Journal; 7/30/2022, Vol. 19 Issue 1, p1-10, 10p

Subject Terms: MEDICAL marijuana, CUSTOMER experience, MEDICAL supplies, MEDICAL logic, MENTAL health, MOLLUSCUM contagiosum

Geographic Terms: AUSTRALIA

Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease.

Authors: Benson, Melissa J., Abelev, Sarah V., Corte, Crispin J., Connor, Susan J., McGregor, Iain S.

Source: Crohn's & Colitis 360; Apr2020, Vol. 2 Issue 2, p1-9, 9p

Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.

Authors: Benson, Melissa J., Abelev, Sarah V., Connor, Susan J., Corte, Crispin J., Martin, Lewis J., Gold, Lucy K., Suraev, Anastasia S., McGregor, Iain S.

Source: Crohn's & Colitis 360; Apr2020, Vol. 2 Issue 2, p1-15, 15p